Published in Medicine and Law Weekly, July 28th, 2006
According to a report from the United States, "The objective of this study was to determine whether intranasal administration of a commercially available FVRCP vaccine to kittens lessened clinical signs and feline herpesvirus 1 (FHV-1) viral shedding when compared to unvaccinated control kittens after FHV-1 challenge."
"Three groups of 10 unvaccinated kittens were administered one dose of vaccine six days (group 1), four days (group 2), or two days (group 3) before...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.